NorthWest Biotherapeutics Inc (NWBO)

[longfellow95]

I think it was actually 3 times he said unblinded when he meant blinded.

Indeed, the unblinded data from the trial strongly supports this as was discussed at ASCO this year.

What key opinion leaders have seen from observing the unblinded data is that DCVax-L seems to have a clinically meaningful survival tail.

New data on the phase 3 trial will likely come in the form of another look at the unblinded data as was done before

Not good really. It's an easy mistake to make, but to make it 3 times in a few paragraphs....

Anyone who is signed up with SoS could ask him by comment, and then we would know for sure.